Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal lupus syndrome.

N Y Olson, C B Lindsley

    American Journal of Diseases of Children (1960)
    |August 1, 1987
    PubMed
    Summary

    Neonatal lupus erythematosus, a rare condition in infants, involves maternal Ro antibodies and clinical signs like heart block. Affected infants may develop lupus later in life.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.

    Rheumatology (Oxford, England)·2007
    Same author

    Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

    The Journal of rheumatology·2001
    Same author

    Overview and report on international registry of sarcoid arthritis in childhood.

    Current rheumatology reports·2000
    Same author

    The pain puzzle: a visual and conceptual metaphor for understanding and treating pain in pediatric rheumatic disease.

    The Journal of rheumatology. Supplement·2000
    Same author

    Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

    Arthritis and rheumatism·1999
    Same author

    Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

    Arthritis and rheumatism·1997

    Area of Science:

    • Pediatrics
    • Immunology
    • Rheumatology

    Background:

    • Neonatal lupus erythematosus (NLE) is a rare syndrome affecting infants within the first six months of life.
    • It is associated with maternal Ro antibodies and can manifest with cardiac, hematologic, or dermatologic symptoms.
    • Congenital heart block, a severe complication, is irreversible and poses a life-threatening risk.

    Purpose of the Study:

    • To summarize the key characteristics and implications of neonatal lupus erythematosus.
    • To highlight the association with maternal Ro antibodies and potential long-term risks for affected infants.

    Main Methods:

    • Review of existing literature on neonatal lupus erythematosus.
    • Analysis of clinical manifestations, serological markers, and long-term outcomes.

    Main Results:

    • NLE is defined by maternal Ro antibodies and infant clinical features (cardiac, hematologic, dermatologic).
    • Congenital heart block is a critical, irreversible manifestation.
    • Mothers may develop connective-tissue diseases later, and infants are at risk for systemic lupus erythematosus in adolescence/adulthood.

    Conclusions:

    • Neonatal lupus erythematosus requires careful monitoring due to potential severe complications.
    • Early identification and understanding of NLE are crucial for managing affected infants and their mothers.
    • Long-term follow-up is essential to monitor for the development of systemic lupus erythematosus in childhood and adulthood.

    Related Experiment Videos